ASML vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Feb 02, 2026

ASML

62.5
AI Score
VS
ASML Wins

GSK

60.8
AI Score

Investment Advisor Scores

ASML

63score
Recommendation
BUY

GSK

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ASML GSK Winner
Forward P/E 42.9185 9.5147 GSK
PEG Ratio 2.434 0.423 GSK
Revenue Growth 4.9% 6.7% GSK
Earnings Growth 7.2% 23.2% GSK
Tradestie Score 62.5/100 60.8/100 ASML
Profit Margin 29.4% 17.1% ASML
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, ASML is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.